Last 23 quarters of trend data · Healthcare · Drug Distributors & Pharmacies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 43.71 | 31.53 | 44.71 | 31.33 | 26.75 | 28.42 | 45.37 | 32.30 | 53.22 | — | 28.40 | — | — | — | — | — | — | — | — | — | — |
| — | +10.9% | -1.5% | -3.0% | -49.7% | — | +59.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.86 | 0.74 | 0.99 | 0.65 | 0.58 | 0.48 | 0.41 | 0.34 | 0.30 | 0.25 | 0.24 | 0.21 | — | — | — | — | — | — | — | — | — |
| — | +53.5% | +144.6% | +93.2% | +93.7% | +92.8% | +66.5% | +61.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 7.82 | 5.72 | 7.46 | 4.74 | 4.34 | 3.54 | 2.92 | 2.30 | 2.20 | 1.80 | 1.48 | 1.21 | — | — | — | — | — | — | — | — | — |
| — | +61.6% | +155.3% | +106.1% | +97.3% | +96.6% | +97.8% | +89.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | 26.76 | 17.15 | 258.03 | 23.25 | 10.55 | 17.48 | 51.76 | 11.58 | 12.05 | 101.13 | — | — | — | — | — | — | — | — | — | — | — |
| — | -1.9% | +398.5% | +100.9% | -12.5% | -82.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 22.28 | 17.80 | 23.12 | 15.91 | 18.29 | 17.50 | 21.42 | 17.63 | 12.08 | 13.58 | 14.82 | 35.25 | — | — | — | — | — | — | — | — | — |
| — | +1.7% | +7.9% | -9.8% | +51.3% | +28.8% | +44.5% | -50.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 53.51 | 22.06 | 29.74 | 20.43 | 24.97 | 25.62 | 39.88 | 32.29 | 20.47 | 25.68 | 34.03 | — | — | — | — | — | — | — | — | — | — |
| — | -13.9% | -25.4% | -36.7% | +22.0% | -0.2% | +17.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 11.8% | 12.3% | 12.7% | 13.3% | 11.6% | 11.8% | 11.9% | 11.8% | 13.8% | 14.0% | 12.8% | 12.8% | 15.5% | 15.9% | 17.2% | 16.5% | 17.1% | 18.1% | 18.6% | 18.5% | 19.1% |
| — | +4.7% | +6.8% | +13.5% | -15.9% | -16.3% | -7.0% | -8.1% | -11.0% | -11.6% | -25.4% | -22.5% | -9.4% | -12.1% | -7.8% | -10.9% | -10.2% | -1.2% | +2.5% | -2.3% | — | |
| Operating Margin | 2.3% | 3.8% | 3.7% | 3.8% | 3.0% | 2.6% | 1.5% | 1.8% | 2.6% | 2.0% | 1.6% | -0.7% | 2.9% | -2.3% | 3.7% | 2.5% | 1.2% | 3.4% | 3.5% | 3.9% | 4.3% |
| — | +44.6% | +142.0% | +115.9% | +17.6% | +34.7% | -2.7% | +362.8% | -9.9% | +184.4% | -56.9% | -126.4% | +140.4% | -168.1% | +5.1% | -35.0% | -72.2% | -6.7% | +4.7% | +39.1% | — | |
| Net Margin | 1.5% | 2.4% | 2.2% | 2.1% | 2.2% | 1.7% | 0.9% | 1.0% | 0.5% | -0.3% | 0.8% | -2.0% | -0.3% | -5.8% | 0.2% | -1.1% | -2.8% | 0.7% | 0.8% | 1.0% | 0.5% |
| — | +41.9% | +149.8% | +100.7% | +314.2% | +691.6% | +9.7% | +151.3% | +290.4% | +95.1% | +343.7% | -89.9% | +90.3% | -974.9% | -77.9% | -209.3% | -660.0% | -0.9% | +2674.1% | +285.8% | — |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 10.8% | 4.7% | 4.3% | 3.8% | 4.2% | 3.1% | 1.6% | 1.8% | 1.0% | -0.5% | 1.3% | -4.2% | -1.0% | -18.2% | 0.5% | -2.7% | -7.1% | 1.6% | 1.9% | 2.1% | 1.1% |
| — | +50.7% | +160.8% | +117.3% | +325.0% | +713.5% | +31.1% | +142.3% | +195.2% | +97.2% | +145.1% | -53.4% | +85.5% | -1268.5% | -72.8% | -228.3% | -758.8% | +16.6% | +2955.4% | +347.7% | — | |
| ROA | 3.1% | 1.6% | 1.4% | 1.2% | 1.2% | 0.9% | 0.5% | 0.5% | 0.3% | -0.1% | 0.4% | -0.8% | -0.1% | -2.4% | 0.1% | — | -1.0% | — | 0.3% | 0.3% | 0.2% |
| — | +75.6% | +197.0% | +134.9% | +352.8% | +744.4% | +35.2% | +161.4% | +330.4% | +93.9% | +384.7% | — | +88.5% | — | -72.9% | — | -761.6% | — | +2770.3% | — | — | |
| ROIC | 4.9% | 3.1% | 2.8% | 2.5% | 1.8% | 1.5% | 0.8% | 0.9% | 1.3% | 0.9% | 0.7% | -0.3% | 1.2% | -0.9% | 2.3% | 1.5% | 0.7% | 1.8% | 1.1% | 1.2% | 1.3% |
| — | +106.9% | +238.3% | +188.9% | +39.1% | +59.3% | +27.8% | +424.1% | +11.4% | +207.5% | -71.1% | -117.9% | +74.9% | -148.6% | +108.8% | +22.3% | -46.6% | +67.0% | -39.0% | -69.8% | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.44 | 1.09 | 1.16 | 1.36 | 1.44 | 1.48 | 1.55 | 1.61 | 1.76 | 1.83 | 1.81 | 1.83 | 5.99 | 5.73 | 4.82 | — | 4.69 | — | 4.71 | 4.61 | 4.71 |
| — | -26.6% | -25.3% | -15.6% | -18.4% | -18.9% | -14.3% | -12.3% | -70.6% | -68.1% | -62.4% | — | +27.8% | — | +2.4% | — | -0.5% | — | +16.5% | — | — | |
| Debt / EBITDA | 5.89 | 11.96 | 12.84 | 15.28 | 18.34 | 20.99 | 30.00 | 29.25 | 21.69 | 27.55 | 32.82 | 85.90 | 30.77 | — | 28.84 | — | 47.83 | — | 32.82 | 31.29 | 68.05 |
| — | -43.0% | -57.2% | -47.7% | -15.5% | -23.8% | -8.6% | -66.0% | -29.5% | — | +13.8% | — | -35.7% | — | -12.1% | — | -29.7% | — | -45.8% | — | — | |
| Current Ratio | 1.57 | 1.62 | 1.59 | 1.74 | 1.57 | 1.79 | 1.76 | 1.73 | 1.33 | 1.35 | 1.33 | 1.26 | 1.17 | 1.33 | 1.50 | — | 1.44 | — | 1.32 | 1.48 | 1.57 |
| — | -9.9% | -9.7% | +0.1% | +18.1% | +32.6% | +32.3% | +37.3% | +13.6% | +1.5% | -11.2% | — | -19.1% | — | +13.2% | — | -8.2% | — | -23.8% | — | — | |
| Quick Ratio | 1.12 | 1.22 | 1.22 | 1.38 | 1.12 | 1.38 | 1.34 | 1.37 | 0.88 | 0.97 | 1.00 | 0.96 | 0.84 | 0.97 | 1.07 | — | 0.98 | — | 0.99 | 1.26 | 1.30 |
| — | -11.4% | -9.3% | +0.5% | +28.2% | +41.8% | +34.1% | +42.1% | +3.9% | +0.4% | -6.3% | — | -13.9% | — | +8.3% | — | -24.8% | — | -25.9% | — | — | |
| Interest Coverage | 1.88 | 5.17 | 3.92 | 3.56 | 2.81 | 2.30 | 1.25 | 1.21 | 1.44 | 1.01 | 0.89 | -0.52 | 0.82 | -0.62 | 1.00 | 0.66 | 0.31 | — | 1.60 | 1.57 | 1.28 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 23 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BTSG stock.
BrightSpring Health Services, Inc. Common Stock's current P/E is 43.7x. The average P/E over the last 4 quarters is 33.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
BrightSpring Health Services, Inc. Common Stock's current operating margin is 2.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking BrightSpring Health Services, Inc. Common Stock's business trajectory between earnings reports.